JPRN-UMIN000022252招募中2 期
Phase II study of low-dose afatinib for elderly patients with non-small cell lung cancer harboring EGFR mutation (based on TDM) - Phase II study of low-dose afatinib for elderly NSCLC patients
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Interstitial lung disease 2) Receiving continuous systemic corticosteroid 3) During pregnancy or lactation 4) Psychological disorder difficult to participate in this clinical study
研究者
相似试验
招募中
2 期
Phase 2 study of afatinib in advanced elderly NSCLC patients harboring sensitive EGFR mutatioJPRN-UMIN000014820Gunma University Graduate School of Medicine40
已完成
2 期
Phase II study of low-dose afatinib for elderly NSCLC patientsLung CancerJPRN-jRCTs041180055Takahashi Toshiaki21
已完成
1 期
Dose-escalation Study of Afatinib in Elderly Patients with EGFR mutation for Non-Small Cell Lung Canceron-small cell lung cancerJPRN-UMIN000016441Hirosaki University Graduate School of Medicine18
已完成
2 期
First-Line Afatinib in Patients Aged 75 or Older With Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation -Multicenter study on the Pharmacokinetics and pharmacogenetics of AfatinibJPRN-UMIN000017050Hokkaido University Hospital, First department of medicine35
已完成
2 期
A phase 2 study of first line low dose afatinib in advanced non-small-cell lung cancer patients with mutated epidermal growth factor receptoron-small cell lung cancerJPRN-UMIN000016444Kyoto Thoracic Oncology Research Group (KTORG)45